FOLFIRINOX relative dose intensity and disease control in advanced pancreatic adenocarcinoma.

Antonin VaryLoïc LebellecFrédéric Di FioreNicolas PenelClaire CheymolEmilia RadFarid El HajbiAstrid LièvreJulien EdelineAndré Michel BimbaiMarie-Cécile Le DeleyAnthony Turpin

Published in: Therapeutic advances in medical oncology (2021)

Pragmatic dose adjustments of FOLFIRINOX should be made by oncologists without considering a loss of effect.

Keyphrases

locally advanced
study protocol
rectal cancer
squamous cell carcinoma
randomized controlled trial
radiation therapy
clinical trial
advanced cancer